Windlas Biotech Limited

NSEI:WINDLAS Stock Report

Market Cap: ₹21.4b

Windlas Biotech Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Komal Gupta

Chief executive officer

₹16.5m

Total compensation

CEO salary percentagen/a
CEO tenure9.2yrs
CEO ownershipn/a
Management average tenure4.7yrs
Board average tenure4.5yrs

Recent management updates

Recent updates

There May Be Underlying Issues With The Quality Of Windlas Biotech's (NSE:WINDLAS) Earnings

Nov 20
There May Be Underlying Issues With The Quality Of Windlas Biotech's (NSE:WINDLAS) Earnings

Windlas Biotech Limited's (NSE:WINDLAS) 30% Share Price Surge Not Quite Adding Up

Nov 01
Windlas Biotech Limited's (NSE:WINDLAS) 30% Share Price Surge Not Quite Adding Up

Windlas Biotech (NSE:WINDLAS) Will Pay A Larger Dividend Than Last Year At ₹5.50

Sep 01
Windlas Biotech (NSE:WINDLAS) Will Pay A Larger Dividend Than Last Year At ₹5.50

Windlas Biotech Limited (NSE:WINDLAS) Stock Rockets 26% But Many Are Still Ignoring The Company

Aug 13
Windlas Biotech Limited (NSE:WINDLAS) Stock Rockets 26% But Many Are Still Ignoring The Company

Should You Be Adding Windlas Biotech (NSE:WINDLAS) To Your Watchlist Today?

Jul 30
Should You Be Adding Windlas Biotech (NSE:WINDLAS) To Your Watchlist Today?

Even With A 27% Surge, Cautious Investors Are Not Rewarding Windlas Biotech Limited's (NSE:WINDLAS) Performance Completely

Jun 07
Even With A 27% Surge, Cautious Investors Are Not Rewarding Windlas Biotech Limited's (NSE:WINDLAS) Performance Completely

Is Now The Time To Put Windlas Biotech (NSE:WINDLAS) On Your Watchlist?

Nov 03
Is Now The Time To Put Windlas Biotech (NSE:WINDLAS) On Your Watchlist?

Windlas Biotech (NSE:WINDLAS) Is Increasing Its Dividend To ₹4.00

Aug 20
Windlas Biotech (NSE:WINDLAS) Is Increasing Its Dividend To ₹4.00

Windlas Biotech (NSE:WINDLAS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

May 23
Windlas Biotech (NSE:WINDLAS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Windlas Biotech Limited's (NSE:WINDLAS) Shares Lagging The Market But So Is The Business

Apr 07
Windlas Biotech Limited's (NSE:WINDLAS) Shares Lagging The Market But So Is The Business

CEO

Komal Gupta

9.2yrs

Tenure

₹16,530,000

Compensation

Mrs. Komal Gupta is the Chief Financial Officer of Windlas Biotech Limited since October 16, 2015 and serves as its Chief Executive Officer since February 08, 2023. She joined Windlas Biotech on October 16...

Leadership Team

NamePositionTenureCompensationOwnership
Komal Gupta
CFO & CEO9.2yrs₹16.53mno data
Ananta Panda
Company Secretary & Compliance Officer3.7yrs₹2.52mno data
Ashok Windlass
Whole-Time Directorno data₹15.60m62.51%
₹ 13.4b
Hitesh Windlass
MD & Executive Director4.7yrs₹17.50m0.000010%
₹ 2.1k
Manoj Windlass
Joint MD & Executive Director4.7yrs₹17.50m0.000030%
₹ 6.4k
Pawan Sharma
Executive Directorno data₹5.07mno data
Mohammed Aslam
President of Sales & Marketingno datano datano data
Om Sule
Site Quality Head5yrsno datano data

4.7yrs

Average Tenure

55.5yo

Average Age

Experienced Management: WINDLAS's management team is considered experienced (4.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Ashok Windlass
Whole-Time Director23.8yrs₹15.60m62.51%
₹ 13.4b
Hitesh Windlass
MD & Executive Director16.9yrs₹17.50m0.000010%
₹ 2.1k
Manoj Windlass
Joint MD & Executive Director18.7yrs₹17.50m0.000030%
₹ 6.4k
Pawan Sharma
Executive Director5.5yrs₹5.07mno data
Gaurav Gulati
Non-Executive Independent Director3.6yrs₹540.00kno data
Vivek Dhariwal
Non-Executive Independent Chairman3.6yrs₹380.00kno data
Srinivasan Venkataraman
Non-Executive Independent Director3.6yrs₹450.00kno data
Prachi Windlass
Non-Executive Director3.6yrsno data0.000010%
₹ 2.1k

4.5yrs

Average Tenure

49yo

Average Age

Experienced Board: WINDLAS's board of directors are considered experienced (4.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 13:51
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Windlas Biotech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution